|
 |
| |
| News and Press Releases Archive |
| |
|
| December 21, 2011 |
Links to articles appearing on international websites and in the media, concerning ViroStatics during 2011
Press Review - Rassegna Stampa 2011 |
| |
|
| November 7, 2011 |
ViroStatics' President and CEO, Dr. Franco Lori, presents at the Second National Health Research Conference in Cernobbio, Italy.
Conference Programme |
| |
|
| October 31, 2011 |
ViroStatics will be at BIO-Europe 2011 in Duesseldorf, Germany. BIO-Europe is Europe's largest partnering conference, serving the global biotechnology industry. The conference annually attracts leading dealmakers from biotech, pharma and finance along with the most exciting emerging companies. |
| |
|
| October 27, 2011 |
ViroStatics is pleased to announce their participation in the 2nd International Workshop on HIV & Aging organized in Baltimore by Virology Education, with the presentation entitled: "AntiViral-Hyperactivation Limiting Therapeutics reduce both HIV and immune hyperactivation restoring immune system damage. A Clinical Proof of Concept." |
| |
|
| October 24, 2011 |
ViroStatics' CEO, Dr. Franco Lori, will be an invited speaker at Pennsylvania Biotech 2011 in Philadelphia, Pennsylvania, USA. |
| |
|
| July 20, 2011 |
ViroStatics' Chief Executive Officer, Dr. Franco Lori, gave a "Late Breaker" presentation entitled "Depletion of naïve CD4+T cell compartment by immune hyperactivation can be rapidly reversed by AntiViral-HyperActivation Limiting Therapeutics (AV-HALTs)" during the International AIDS Society conference (IAS 2011) in Rome, Italy.
Press Release document.pdf
Comunicato Stampa.pdf |
| |
|
| June 20, 2011 |
ViroStatics CEO, Franco Lori, MD, will be an invited speaker at the June 2011 BIO International Convention in Washington, DC. |
| |
|
| April 6, 2011 |
Online links to articles and videos on ViroStatics' Scientific findings published on International websites after CROI 2011
Press review
Rassegna stampa |
| |
|
| March 2, 2011 |
ViroStatics is pleased to announce their participation in the CROI 2011 conference in Boston with the presentation "Prompt, Significant Reduction of Activation and Proliferation Markers in CD4+ and CD8+ T Cell Subsets Despite Incomplete Viral Suppression: Proof-of-Concept for AV-HALTs: New Class of Anti-HIV Therapeutics Inhibiting Both HIV Replication and Immune Activation"
Press Release Article
Comunicato stampa |
| |
|
| February 15, 2011 |
ViroStatics' Chief Executive Officer, Dr. Franco Lori, gave an invited presentation entitled "Dual Inhibitors of HIV Replication and Immune Hyperactivation" during a Scientific Seminar organized by the Sardinian Science and Technology Park in Pula (Southern Sardinia), Italy
Related article
Articolo correlato |
| |
|
| October 30, 2010 |
ViroStatics announces the publication on the scientific journal British Journal of Pharmacology of the article "Strategies to improve efficacy and safety of a novel class of antiviral hyper-activation-limiting therapeutic agents: the VS411 model in HIV/AIDS" |
| |
|
| July 22, 2010 |
Immunacia's ViroStatics and Genetic Immunity are pleased to announce their participation in the "NAPWA Community Research Forum, Research Advances from Therapeutic HIV Vaccines and Other Immune-Based Therapies" during the XVIII International AIDS Conference, Vienna, Austria |
| |
|
| July 19, 2010 |
Immunacia's ViroStatics reports Phase II data on VS411, an AV-HALT for treating HIV/AIDS, during the XVIII International AIDS Conference, Vienna, Austria |
| |
|
| June 11, 2010 |
ViroStatics and Vichem Chemie Announce Strategic Partnership to Identify and Develop Kinase Inhibitors for the Treatment of HIV/AIDS and Other Chronic Diseases |
| |
|
| May 3, 2010 |
Dr. James Chafouleas, former Head of Global Licensing – Virology at Boehringer Ingelheim Canada (Ltd.), Joins ViroStatics and Genetic Immunity as Strategic Adviser |
| |
|
| March 1, 2010 |
ViroStatics organizes a Seminar "High-End Flow cytometry analysis for everyone". The event will take place at Porto Conte Ricerche, Alghero (Room Anghelu Ruju) from 11.00 till 13.00 |
| |
|
| May 20, 2009 |
ViroStatics' Dr. Franco Lori to Present During 2009 BIO International Convention in Atlanta |
| |
|
| March 29, 2009 |
ViroStatics acquires Library of Oncological/Antiviral Compounds from the University of Siena |
| |
|
| March 18, 2009 |
ViroStatics' Chief Executive Officer, Dr. Franco Lori, to Present During BIO-Europe Spring 2009 on 18 March 2009 |
| |
|
| December 10, 2008 |
ViroStatics' President and CEO, Dr. Franco Lori, to address HIV DART 2008 in Puerto Rico |
| |
|
| November 12, 2008 |
The CDO, Dr. Michael Stevens, Presenting During Rodman & Renshaw's Tenth Annual Global Healthcare Conference |
| |
|
| October 1, 2008 |
The CEO, Dr. Franco Lori, speaking at the prestigious 2nd World Conference on Magic Bullets, (Ehrlich II) in Nürnberg, Germany on Saturday, October 4th 2008 |
| |
|
| May 28, 2008 |
 Franco Lori on Sky Radio |
| |
|
| May 26, 2008 |
 ViroStatics on IMS Health Company Focus |
| |
|
| May 13, 2008 |
ViroStatics Doses First Patient in Phase IIa Trial of VS411 for the Treatment of HIV Infection |
| |
|
| February 27, 2008 |
|
|
